Crypto Market Cap, BTC/USD, ETH/USD, USDT/USD, XRP/USD, Bitcoin
Apple, Advanced Micro Devices Inc, Amazon Com Inc, TESLA INC, NETFLIX INC, Facebook Inc
S&P 500, Nasdaq 100, Dow 30, Russell 2000, U.S. Dollar Index, Bitcoin Index
US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y
CRSP 1D Time Frame 1-2 weeks horizon Price trending up for the past months respecting the 21ema. We are seeing another pullback approaching the 21ema which also happens to be around the 61.8% fib level. MACD lines are pointing down but over all trend is upwards, histogram suggest weakening bullish momentum (could be a sign of divergence). Stochastics is pointing...
CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Single-gene disorders aren't the only programs in CRISPR Therapeutics' pipeline. It's currently enrolling participants in studies testing CAR-T therapies, which use gene-editing to give immune cells the ability to recognize and attack...
CRSP is currently consolidating in a bull pennant, with near term support at the 50% fibonacci retracement of AB swing @ 179. Let's see if it will make another move up soon. Disclaimer: This is just my own analysis and opinion for discussion and is not a trade advice. Kindly do your own due diligence and trade according to your own risk tolerance. Thank you. ...
Here is my short case on CRSP: - at the top of trading channel started since Feb 2020 - over bought reading on RSI - both PPO and RSI shows very clear divergence high Starting building a position as it hits the top of the channel and scale in as it moves down. Impulsive break of the wedge should move it down to the support at $161. Reaction will be likely,...
NASDAQ:CRSP Continuation wedge after a big break out. The trading range has got very tight with buyers and sellers starting to agree on the current price. Potential buy through 152.5 against 147.
I don't know if this will ever make a dip I can buy. The chart says up up up, and then some more up. May need to grab some long term commons if I cannot find an entry at a dip.
CRSP has had a good initial recovery from the 20day. Looking to play a continuation if it can break the last high. NTLA is also looking like a similar setup, I will be looking to see who leads here.
Incredible run since October.. Ark Is invested heavily here. Targets are green lines
Price has been going up with the CMF diverging negatively -- could be a warning sign. 20 period CMF even crossed down 0. Disclaimer, this is only for entertainment and education purposes and doesn't serve by any means as a buy or sell recommendation. Personally I hold both long term long positions and occasionally short term short position, for disclosure purpose.
If we drop below our middle line this is a huge buy. Long term I am very bullish.
A lot of volume, well above the average for CRSP. Accumulation or distribution ?
Yellow lines - weekly channel Red lines - Daily channel Green line - Target Crispr has been on a tear for the last 90 days with new medical break throughs. Currently in a uptrend pattern, but hit the top of its channel and got rejected.. looking for a pullback to our target area ( greenline) , then continuation on uptrend
Description CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious human diseases. It develops its products using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), a gene editing technology that allows for precise directed changes to genomic DNA. It...
Started 1/4 of my position in CRSP today. Levels: Bullish above 164 (x) I will add another 1/4 of my position at 163 and the rest as the tape progresses Bearish below 147 (x) I will add the other 3/4 of my position if we drop below this level and hedge with puts My 3-month PT is 190 fuelled by business updates, more funding, and CTX001 updates
CRSP January strategies S1: consolidate 150USD S2: bear 100USD S3: bull 180USD
one of the hottest biotech stocks that may need to be looked into with gene editing...I would wait for trials and phases to be looked into and due diligence with biotech. Genomics may be the new hot stocks that will help define 2021.
***Scroll along the chart to see this years key data*** About Crispr Therapeutics CRISPR Therapeutics AG is a gene editing company focused on the development of CRISPR/Cas9- based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the...
Just an historical view of the trading in CRSP on a weekly basis with weekly Bollinger Bands (50 & 200 weeks).